Monthly Archives: October 2022

Pediatrics Letter

As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]

By |2022-11-07T19:25:45+00:00October 31st, 2022|Latest News, Press Release, Special Announcements|0 Comments

MSSNY Pulse: October 28, 2022

Message from MSSNY President Parag Mehta, MD: The Power of Trust Colleagues: Trust is the most powerful force underlying the success of every organization. “When people trust each other, they can make decisions quickly and take risks knowing that it’s okay to fail,” says Nicole Umana, global agile innovation human intelligence office at Mars, Inc.

By |2022-11-07T21:22:01+00:00October 28th, 2022|Pulse|0 Comments

MSSNY Pulse: October 21, 2022

Message from MSSNY President Parag Mehta, MD: Keep Your Finger on the Pulse of New York Medicine Colleagues: MSSNY Pulse App: Keep your finger on the pulse of New York medicine and get the latest news on demand with our new MSSNY Pulse app. When you download the app, you’ll be able to read MSSNY

By |2022-11-07T21:13:30+00:00October 21st, 2022|Pulse|0 Comments

MSSNY Pulse: October 14, 2022

Message from MSSNY President Parag Mehta, MD: Life Long Learning: A Look in the Rear View Mirror and a Peek Ahead Colleagues: I am excited to announce a one-hour webinar on October 25 entitled Life Long Learning: A Look in the Rear View Mirror and a Peek Ahead, presented by esteemed Harvard Medical School Professor

By |2022-11-07T21:10:40+00:00October 14th, 2022|Pulse|0 Comments

FDA Authorizes Use of COVID Bivalent Vaccine for Pediatric Population

Yesterday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines. CDC’s Director Dr. Rochelle Walensky released a statement and signed a decision memo recommending updated (bivalent) COVID-19 boosters for children five years and older. This expands on CDC's recommendation issued September 1, 2022, for updated COVID-19 boosters of people ages 12 and older.

By |2022-11-07T19:23:06+00:00October 13th, 2022|Covid Resources|0 Comments
Go to Top